Foxo Technologies Inc
FOXO1.570USD
+0.933+146.82%
Handelsschluss 05/09, 16:00（ET）Kurse um 15 Minuten verzögert
36.99MMarktkapitalisierung
--KGV TTM
mehr Informationen über Foxo Technologies Inc Unternehmen
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Unternehmensinformationen
Unternehmens-codeFOXO
Name des UnternehmensFoxo Technologies Inc
IPO-datumDec 11, 2020
Gegründet am2020
CEOMr. Seamus Lagan
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeDec 11
Addresse477 South Rosemary Avenue
StadtWEST PALM BEACH
BörseNYSE American Consolidated
LandUnited States of America
Postleitzahl33401
Telefon16128000059
Websitehttp://delwinds.com/
Unternehmens-codeFOXO
IPO-datumDec 11, 2020
Gegründet am2020
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
333.00
-60.02%
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Martin C. Ward
Mr. Martin C. Ward
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
333.00
-60.02%
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Martin C. Ward
Mr. Martin C. Ward
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Fri, May 9
Update-Zeit: Fri, May 9
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Clearthink Capital Partners LLC
1.53%
GWG Wind Down Trust
1.18%
Kr8 ai Inc
0.60%
UBS Financial Services, Inc.
0.36%
Jane Street Capital, L.L.C.
0.30%
Other
96.03%
Aktionärsstatistik
Aktionäre
Anteil
Clearthink Capital Partners LLC
1.53%
GWG Wind Down Trust
1.18%
Kr8 ai Inc
0.60%
UBS Financial Services, Inc.
0.36%
Jane Street Capital, L.L.C.
0.30%
Other
96.03%
Art
Aktionäre
Anteil
Corporation
3.31%
Investment Advisor
0.64%
Research Firm
0.47%
Investment Advisor/Hedge Fund
0.46%
Hedge Fund
0.07%
Other
95.05%
Institutionelle Beteiligung
Update-Zeit: Mon, Mar 3
Update-Zeit: Mon, Mar 3
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
44
297.90K
11.61%
-32.78K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
2023Q1
129
1.99M
69.67%
-1.77M
2022Q4
123
1.73M
63.52%
-18.64M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Clearthink Capital Partners LLC
600.00K
2.55%
+600.00K
--
Dec 01, 2023
GWG Wind Down Trust
464.67K
1.97%
+464.67K
--
Aug 11, 2023
Kr8 ai Inc
237.04K
1.01%
--
--
Nov 14, 2024
UBS Financial Services, Inc.
139.89K
0.59%
+139.89K
--
Dec 31, 2024
Jane Street Capital, L.L.C.
117.05K
0.5%
+117.05K
--
Dec 31, 2024
Sabby Management, LLC
80.56K
0.34%
+80.56K
--
Dec 31, 2024
SBI Securities Co., Ltd.
39.33K
0.17%
+39.33K
--
Dec 31, 2024
Geode Capital Management, L.L.C.
42.46K
0.18%
--
--
Dec 31, 2024
Corbin Capital Partners, L.P.
27.48K
0.12%
--
--
Dec 31, 2024
Susquehanna International Group, LLP
27.23K
0.12%
-76.72K
-73.81%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Datum
Art
Verhältnis
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1